Your search history is turned on.
Date: May 6, 2024 Jurisdictions: All jurisdictions
Growing Body of Clinical Evidence Points to the Potential of Profound Medicals TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum So far this year alone, 25 TULSA-related scientific research presentations have been delivered at major medical meetings around the world Of those, eight (8) presentations were from leading urologists at AUA 2024...
Date: April 24, 2024 Jurisdictions: All jurisdictions
VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: PROFOUND MEDICAL CORP 1 Proxy with Request for Financial Statements - Registered Securityholders 2 Voting Instruction Form with Request for Financial Statements - NOBOs, ESPP Holders 3 Notice of Meeting Combined with Information Circular 4 Proxy Return Envelope Yours truly, ...
Date: April 23, 2024 Jurisdictions: All jurisdictions
PROFOUND MEDICAL CORP (the "Corporation") Annual General Meeting May 15, 2024 at 10:00 AM (Canada/Eastern Standard) Profound Medical Corp. 2400 Skymark Ave. Unit #6, Mississauga, Ontario L4W5K5 (the "Meeting") Proxy Voting Guidelines and Conditions THIS PROXY IS SOLICITED BY OR ON BEHALF OF THE MANAGEMENT OF THE CORPORATION. THIS PROXY SHOULD BE READ IN CONJU...
Microsoft Word - Profound Medical Corp - 2024 Management Information Circular -FINAL PROFOUND MEDICAL CORP. NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 AND MANAGEMENT INFORMATION CIRCULAR DATED AS OF APRIL 5, 2024 PROFOUND MEDICAL CORP. NOTICE OF ANNUAL GEN...
PROFOUND MEDICAL CORP. NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT an annual general meeting (the Meeting) of the holders (the Shareholders) of common shares (Common Shares) in the capital of Profound Medical Corp. (the Corporation) will be held at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario, L4W 5K5, on Wednesday, May 15, 2024 at 10:00 a.m. (Toronto time) ...
Date: April 22, 2024 Jurisdictions: All jurisdictions
Profound Medical to Release First Quarter 2024 Financial Results on May 9 Conference Call to Follow TORONTO, April 22, 2024 -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2024 financial results a...
Date: April 9, 2024 Jurisdictions: All jurisdictions
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference TORONTO, April 09, 2024 -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (Profound or the Company), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Co...
Date: March 11, 2024 Jurisdictions: All jurisdictions
VIA ELECTRONIC TRANSMISSION TO ALL APPLICABLE EXCHANGES AND COMMISSIONS: RE: PROFOUND MEDICAL CORP Confirmation of Notice of Record and Meeting Dates We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities. We advise the following with respect to the upcoming Annual General Meeting of Security Holders...
Date: March 7, 2024 Jurisdictions: All jurisdictions
PROFOUND MEDICAL CORP. ANNUAL INFORMATION FORM FOR THE YEAR ENDED DECEMBER 31, 2023 March 7, 2024 TABLE OF CONTENTS Page SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS ......................................................... 1 MARKET AND INDUSTRY DATA .....................................
Microsoft Word - Signed FORM 52-109F1_CFO Mar 7, 2024 FORM 52-109F1 CERTIFICATION OF ANNUAL FILINGS FULL CERTIFICATE I, Rashed Dewan, the Chief Financial Officer of Profound Medical Corp., certify the following: 1. Review: I have reviewed the AIF, annual financial statements and annual MD&A including, for greater certainty, all documents and information t...